Skip to main content

Table 2 Cohort characteristics of esophageal cancer patients

From: Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

Clinicopathological characteristics TYK2 protein expression level
Low (n = 45) High (n = 46) P
Gender
 Male 29 (64.4%) 39 (84.8%) 0.113
 Female 16 (35.6%) 7 (15.2%)  
Age
 ≤ 60 14 (31.1%) 17 (37.0%) 0.761
 > 60 31 (68.9%) 29 (63.0%)  
Tumor size
 ≤ 5 cm 31 (68.9%) 25 (54.3%) 0.528
 > 5 cm 14 (31.1%) 21 (45.7%)  
Histological grade
 Well/moderately 30 (66.7%) 37 (80.4%) 0.355
 Poorly 15 (33.3%) 9 (19.6%)  
T classification
 T1 4 (8.9%) 2 (4.3%) 0.543
 T2 7 (15.6%) 5 (10.9%)  
 T3 32 (71.1%) 38 (82.6%)  
 T4 2 (4.4%) 1 (2.2%)  
N classification
 N0 22 (48.9%) 19 (41.3%) 0.448
 N1 16 (35.6%) 14 (30.4%)  
 N2 6 (13.3%) 10 (21.8%)  
 N3 1 (2.2%) 3 (6.5%)  
Clinical stage
 1 5 (11.1%) 2 (4.4%) 0.033
 2 20 (44.5%) 19 (41.3%)  
 3 18 (40.0%) 21 (45.6%)  
 4 2 (4.4%) 4 (8.7%)